SCYNEXIS, Inc. (SCYX): Price and Financial Metrics
SCYNEXIS, Inc. (SCYX)
Today's Latest Price: $1.24 USD
0.04 (3.33%)
Updated Nov 13 10:23am
Add SCYX to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 215 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
SCYX Stock Summary
- The capital turnover (annual revenue relative to shareholder's equity) for SCYX is 0.02 -- better than just 8.56% of US stocks.
- Of note is the ratio of Scynexis Inc's sales and general administrative expense to its total operating expenses; merely 12.9% of US stocks have a lower such ratio.
- SCYX's price/sales ratio is 302.03; that's higher than the P/S ratio of 99.07% of US stocks.
- If you're looking for stocks that are quantitatively similar to Scynexis Inc, a group of peers worth examining would be CRNX, QURE, CLSD, FIXX, and RETA.
- Visit SCYX's SEC page to see the company's official filings. To visit the company's web site, go to www.scynexis.com.
SCYX Daily Price Range
SCYX 52-Week Price Range
SCYX Stock Price Chart More Charts
SCYX Price/Volume Stats
| Current price | $1.24 |
| Prev. close | $1.20 |
| Day low | $1.20 |
| Day high | $1.25 |
| 50-day MA | $1.12 |
| 200-day MA | $1.28 |
| 52-week high | $1.90 |
| 52-week low | $0.35 |
| Volume | 125,049 |
| Avg. volume | 650,253 |
| Dividend yield | N/A |
| Market Cap | 69.08M |
SCYNEXIS, Inc. (SCYX) Company Bio
SCYNEXIS, Inc., a pharmaceutical company, develops and commercializes novel anti-infectives to address unmet therapeutic needs. Its lead product candidate includes SCY-078, which is in Phase I clinical trials of the intravenous formulation; Phase II clinical trials for the treatment of invasive candida infections; and Phase II clinical trials for unmet medical needs, such as vulvovaginal candidiasis. The company was founded in 1999 and is based in Jersey City, New Jersey.
Top Stories View All
Is HELE the World’s Most Beautiful Stock?
3 Trading Strategies for 3 Market Outcomes
Why is Thursday Such an Important Day for Aurora Cannabis (ACB)?
Best & Worst Performing Stock Industries for November 12, 2019
Best & Worst Performing Small Cap Stocks for November 12, 2019
View All Top Stories
Loading social stream, please wait...